Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.42 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 2/20 | 0.39 |
| ▸ | GABRD | O14764 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16831513 | 1.00 | TSHR (0.42) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL16057346 | 1.00 | TSHR (0.42) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL7078093 | 0.86 | KDM1A (0.43) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL8073587 | 0.86 | KDM1A (0.43) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL29888598 | 0.86 | BLM (0.42) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL23494364 | 0.85 | TSHR (0.38) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL3814942 | 0.85 | KDM1A (0.42) | TSHRGABRR1GABRR2BLMGABRR3 | |
| SCHEMBL4410929 | 0.85 | PPARA (0.52) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL4410926 | 0.85 | PPARA (0.52) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL3814938 | 0.85 | KDM1A (0.42) | TSHRGABRR1GABRR2BLMGABRR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103254350-B | Spun bonded lining cloth co polystyrene acrylic ester emulsion and preparation method thereof | SHANGHAI DONGRUI PLASTIC PRODUCTS CO., LTD. (CN) | 2016-03-16 | — | — | CN | claimed |
| CN-103254350-A | Polystyrene-acrylate emulsion for woven adhesive lining cloth, and preparation method thereof | SHANGHAI DONGRUI PLASTIC PRODUCTS CO LTD | 2013-08-21 | — | — | CN | claimed |
| US-5876492-A | Ink compositions containing esters | XEROX CORPORATION (US) | 1999-03-02 | — | — | US | claimed |
| EP-4692041-A1 | METHOD FOR PRODUCING BIO-DERIVED ESTER COMPOUND, BIO-DERIVED ESTER COMPOUND PRODUCED THEREBY, COSMETIC OR DETERGENT CONTAINING BIO-DERIVED ESTER COMPOUND, AND METHOD FOR REDUCING ODOR OF ESTER COMPOUND | ADEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| CN-120479350-A | Preparation facilities of isooctenoate stannous | 浙江鸿浩科技有限公司 | 2025-08-15 | — | — | CN | disclosed |
| WO-2025063309-A1 | DETERGENT COMPOSITION, METHOD FOR PRODUCING SAME, AND DETERGENT PRODUCT CONTAINING DETERGENT COMPOSITION | 味の素株式会社 | 2025-03-27 | — | — | WO | disclosed |
| WO-2024204392-A1 | METHOD FOR PRODUCING BIO-DERIVED ESTER COMPOUND, BIO-DERIVED ESTER COMPOUND PRODUCED THEREBY, COSMETIC OR DETERGENT CONTAINING BIO-DERIVED ESTER COMPOUND, AND METHOD FOR REDUCING ODOR OF ESTER COMPOUND | 株式会社ADEKA | 2024-10-03 | — | — | WO | disclosed |
| CN-114423774-A | Ascaroside derivatives and methods of use | 加利福尼亚技术学院 | 2022-04-29 | — | — | CN | disclosed |
| CN-112851498-A | Preparation method and application of stannous isooctenoate | 潍坊加易加生物科技有限公司 | 2021-05-28 | — | — | CN | disclosed |
| CN-111492108-A | Method for producing a multi-ply paper | 索理思科技开曼公司 | 2020-08-04 | — | — | CN | disclosed |
| US-20190002454-A1 | NRF2 Regulators | GLAXOSMITHKLINE IP DEV LTD (GB) | 2019-01-03 | — | — | US | disclosed |
| CN-103491777-A | Cathepsin c inhibitors | GLAXOSMITHKLINE LLC | 2014-01-01 | — | — | CN | disclosed |
| US-20130071544-A1 | Food Products, Seasonings and Processing Methods Thereof | ALEXANDER RUBEN E (US) | 2013-03-21 | — | — | US | disclosed |
| EP-1795566-B1 | RESIN COMPOSITION FOR WATER-BASED COATING MATERIAL, WATER-BASED COATING MATERIAL, AND PROCESS FOR PRODUCING RESIN COMPOSITION FOR WATER-BASED COATING MATERIAL | DAINIPPON INK & CHEMICALS (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-7737213-B2 | Resin composition for water paint, water paint, and production method for resin composition for water paint | DIC CORPORATION (JP) | 2010-06-15 | — | — | US | disclosed |
| US-20080167424-A1 | Resin Composition For Water Paint, Water Paint, And Production Method For Resin Composition For Water Paint | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2008-07-10 | — | — | US | disclosed |
| EP-1795566-A1 | RESIN COMPOSITION FOR WATER-BASED COATING MATERIAL, WATER-BASED COATING MATERIAL, AND PROCESS FOR PRODUCING RESIN COMPOSITION FOR WATER-BASED COATING MATERIAL | Dainippon Ink and Chemicals, Incorporated (JP) | 2007-06-13 | — | — | EP | disclosed |
| EP-0903382-A1 | Semi-solid hot melt ink compositions containing esters | XEROX CORPORATION (US) | 1999-03-24 | — | — | EP | disclosed |
| US-5876492-A | Ink compositions containing esters | XEROX CORPORATION (US) | 1999-03-02 | — | — | US | disclosed |
| EP-0373057-A1 | Process for the preparation of (2-propyl)2-pentenoic acid and its esters | ELF SANOFI (FR) | 1990-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190002454-A1 | NRF2 Regulators | NFE2L2, KEAP1, NQO1 | TSHR 2353/4885GABRR1 1265/4885GABRR2 1037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.